UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
(Exact Name of Registrant as Specified in Charter)
(State or Other | (Commission | (IRS Employer | ||||||||||||
Jurisdiction of Incorporation) | File Number) | Identification No.) | ||||||||||||
(Address of Principal Executive offices) | (Zip Code) | |||||||||||||
Registrant’s telephone number, including area code: (201 ) 587-8541
Former name or former address, if changed since last report: N/A
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2.):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | |||||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory
On December 30, 2024 , due to health reasons, Dr. Richard West submitted his resignation from the Board of Directors (the “Board”) of Alexander’s, Inc. (the “Company”), including from his role as Chair of the Audit Committee of the Board (the “Audit Committee”) and Chair of the Compensation Committee (the “Compensation Committee”), effective as of January 1, 2025.
Effective January 1, 2025, the Board reduced the size of the Board to seven (7) directors, eliminated its Executive Committee and appointed Mandakini Puri as Chair of the Audit Committee and Wendy A. Silverstein as Chair of the Compensation Committee.
Dr. West’s decision to resign was not the result of any disagreement with management or the Board, on any matter relating to the Company’s operations, policies, or practices.
The Company is very grateful for Dr. West’s extraordinary dedication over the course of his many years of service on the Board.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ALEXANDER’S, INC. | |||||||||||
(Registrant) | |||||||||||
| By: | /s/ Gary Hansen | ||||||||||
| Name: | Gary Hansen | ||||||||||
| Title: | Chief Financial Officer (duly authorized officer and principal financial and accounting officer) | ||||||||||
Date: December 30, 2024
3